ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
6,114.63
-0.01%
US Tech 100
21,524.40
0.41%
Dow Jones
44,546.08
-0.37%
Brent Oil
74.39
0.00%
Bitcoin
97,626.60
0.03%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Passage Bio Inc (PASG) Quote

Passage Bio Inc

Passage Bio Inc (PASG)

NASDAQ
0.56
0.0368
(7.03%)
Closed February 15 4:00PM
Delayed by 15 minutes
0.5621
0.0021
(0.37%)
After Hours: 7:59PM
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
0.56
Bid
0.55
Ask
0.59
Volume
200,064
0.5263 Day's Range 0.5999
0.451 52 Week Range 1.79
Market Cap
34.59M
Previous Close
0.5232
Open
0.5537
Last Trade
10
@
0.588
Last Trade Time
Financial Volume
$ 112,759
VWAP
0.563614
Average Volume (3m)
798,908
Shares Outstanding
61,767,286
Dividend Yield
-
PE Ratio
-0.34
Earnings Per Share (EPS)
-1.65
Revenue
-
Net Profit
-102.06M

About Passage Bio Inc

Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease.

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
www.passagebio.com/home/default.aspx
Headquarters
Wilmington, Delaware, USA
Founded
-
Passage Bio Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker PASG. The last closing price for Passage Bio was $0.52. Over the last year, Passage Bio shares have traded in a share price range of $ 0.451 to $ 1.79.

Passage Bio currently has 61,767,286 shares outstanding. The market capitalization of Passage Bio is $32.32 million. Passage Bio has a price to earnings ratio (PE ratio) of -0.34.

Ask ADVFN Intelligence (AI)

PASG Latest News

More News

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
February 12 2025
PASG (7.03%)

Form 8-K - Current report
Edgar (US Regulatory)
January 31 2025
PASG (7.03%)

Form 8-K - Current report
Edgar (US Regulatory)
January 10 2025
PASG (7.03%)

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Edgar (US Regulatory)
November 14 2024
PASG (7.03%)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Edgar (US Regulatory)
November 14 2024
PASG (7.03%)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Edgar (US Regulatory)
November 13 2024
PASG (7.03%)

Form 8-K - Current report
Edgar (US Regulatory)
November 13 2024
PASG (7.03%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.0497-8.151549942590.60970.60970.50331390030.55113604CS
4-0.05-8.196721311480.610.630.50331528690.58588439CS
120.023.70370370370.541.330.47097989080.86794632CS
26-0.216-27.83505154640.7761.330.4514843460.8061977CS
52-0.41-42.26804123710.971.790.4513780650.95884957CS
156-3.6-86.53846153854.164.390.4513388011.31105625CS
260-21.71-97.485406376322.2738.230.4513256396.75500702CS

PASG - Frequently Asked Questions (FAQ)

What is the current Passage Bio share price?
The current share price of Passage Bio is $ 0.56
How many Passage Bio shares are in issue?
Passage Bio has 61,767,286 shares in issue
What is the market cap of Passage Bio?
The market capitalisation of Passage Bio is USD 32.32M
What is the 1 year trading range for Passage Bio share price?
Passage Bio has traded in the range of $ 0.451 to $ 1.79 during the past year
What is the PE ratio of Passage Bio?
The price to earnings ratio of Passage Bio is -0.34
What is the reporting currency for Passage Bio?
Passage Bio reports financial results in USD
What is the latest annual profit for Passage Bio?
The latest annual profit of Passage Bio is USD -102.06M
What is the registered address of Passage Bio?
The registered address for Passage Bio is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Passage Bio website address?
The website address for Passage Bio is www.passagebio.com/home/default.aspx
Which industry sector does Passage Bio operate in?
Passage Bio operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
JTAIJet AI Inc
$ 6.02
(133.33%)
101.64M
SRMSRM Entertainment Inc
$ 0.6999
(95.50%)
248.48M
WRDWeRide Inc
$ 31.4877
(83.39%)
20.57M
INLFINLIF Limited
$ 16.27
(80.58%)
7.67M
MBRXMoleculin Biotech Inc
$ 2.1201
(66.94%)
134.88M
BLACBellevue Life Sciences Acquisition Corporation
$ 3.08
(-56.31%)
430.77k
BLACUBellevue Life Sciences Acquisition Corporation
$ 3.36
(-52.68%)
5.21k
CSAICloudastructure Inc
$ 19.0001
(-49.58%)
1.03M
NEXNNexxen International Ltd
$ 10.30
(-49.16%)
164.82k
BSLKBolt Projects Holdings Inc
$ 0.6626
(-46.13%)
13.4M
CNSPCNS Pharmaceuticals Inc
$ 0.1415
(31.26%)
480.49M
MGOLMGO Global Inc
$ 0.7176
(-15.08%)
411.17M
SRMSRM Entertainment Inc
$ 0.6999
(95.50%)
248.48M
INTCIntel Corporation
$ 23.60
(-2.20%)
225.04M
NVDANVIDIA Corporation
$ 138.85
(2.63%)
189.56M

PASG Discussion

View Posts
glenn1919 glenn1919 1 month ago
pasg.....................out
👍️0
tw0122 tw0122 2 months ago
373,645
👍️0
tw0122 tw0122 2 months ago
Insider acquired shares 12-31
👍️0
tw0122 tw0122 2 months ago
Pass some gas PASG .67
👍️0
PonkenPlonken PonkenPlonken 2 months ago
make or break
👍️0
PonkenPlonken PonkenPlonken 2 months ago
Wedbush pump losing steam
the dilemma is the readouts are right around the corner
👍️0
Stumblebum Stumblebum 3 months ago
Next week should be interesting….will Pasg hold its gains or tank…was it a pump and dump day…..15 million share volume today …..massive increase …..hmmmmm
👍️0
PonkenPlonken PonkenPlonken 3 months ago
EVERYTHING the analyst said today was well known.
Direct CNS delivery... AAV gene therapy pioneer thinks AAV gene therapy will work in FTD too.... First one of its kind in FTD.... Then in recent months we got about a million validations of that ---------- No one bit this? They didnt believe him? Because he left again for head of gene therapy at PENNs and then went on to found 2 new companies instead of linger around at PASG at 60 something years?
No one believed he gave the steering wheel to Mr Chou because Wilson thought Chou could finish the job?
👍️0
PonkenPlonken PonkenPlonken 3 months ago
Analyst says most basic stuff and they go crazy?
👍️0
PonkenPlonken PonkenPlonken 3 months ago
will it keep going?
👍️0
PonkenPlonken PonkenPlonken 6 months ago
big pop coming. Science hated for no reason. Founder is gene therapy authority. AAV tech works.
👍️0
Monksdream Monksdream 6 months ago
PASG 10Q due AUGUST5
👍️0
PonkenPlonken PonkenPlonken 6 months ago
See the first rally on this after the big bar on the first data release. They saw something and took a seat. A lot of shares were bought. Thats because the platform works and will -- veeery surprisingly -- produce great data.
👍️0
PonkenPlonken PonkenPlonken 6 months ago
this is not a daytrade. I am invested here, waiting for the crowd/data.
I think a deal is coming on data release.... its a neglected approach. Founder is a genius and gene therapy authority, popularized AAVs. All the recent bio winners use them.
Happy trading
👍️0
Awl416 Awl416 7 months ago
Ahem..
👍️0
PonkenPlonken PonkenPlonken 7 months ago
Going to explode on the next readout

Passage Bio Announces Positive Feedback from FDA on Expansion of upliFT-D Trial of PBFT02 to Include FTD-C9orf72 Patients
Agency feedback from Type C meeting process supports the company's proposed clinical development plans to expand the upliFT-D trial to assess PBFT02 in FTD patients with C9orf72 gene mutations


👍️0
Monksdream Monksdream 7 months ago
There are close to 1,000 listed med tech companies
Only so many can garner serious institutional interest
👍️0
PonkenPlonken PonkenPlonken 7 months ago
I wonder... when will people realize that the AAV stuff is great... CADL, SLDB, PASG

The founder certainly thinks so... and he is the authority on the topic:
"Dr. James M. Wilson serves as the Director of the Gene Therapy Program (GTP) at Penn's Perelman School of Medicine."

"The Wilson lab identified a new type of vector based on novel isolates of adeno-associated viruses which have become best in class for gene therapy. More recently Dr. Wilson’s laboratory has focused on improved vectors for gene therapy and clinical applications of genome editing and mRNA therapy.The Wilson lab identified a new type of vector based on novel isolates of adeno-associated viruses which have become best in class for gene therapy. More recently Dr. Wilson’s laboratory has focused on improved vectors for gene therapy and clinical applications of genome editing and mRNA therapy."
👍️0
Monksdream Monksdream 9 months ago
PASG under $2
👍️0
Monksdream Monksdream 9 months ago
PASG under $2
👍️0
Sirpeter Sirpeter 11 months ago
Running... boom!!!
👍️0
Monksdream Monksdream 11 months ago
PASG under $2
👍️0
glenn1919 glenn1919 11 months ago
PASG..........................https://stockcharts.com/h-sc/ui?s=PASG&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 12 months ago
PASG new 52 week high
👍️0
TrendTrade2016 TrendTrade2016 12 months ago
PASG setting up nicely. Another beautiful call by the only true chartist around
👍️0
Sirpeter Sirpeter 12 months ago
Yup yup yup...
👍️0
TrendTrade2016 TrendTrade2016 12 months ago
PASG...NEXT CRDL
👍️0
glenn1919 glenn1919 12 months ago
PASG..............................https://stockcharts.com/h-sc/ui?s=PASG&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 12 months ago
PASG..............................https://stockcharts.com/h-sc/ui?s=PASG&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 12 months ago
PASG under $2
👍️0
turning stone turning stone 1 year ago
As a new investor in PASG, I am looking forward to another high roller in the next number of years. I bought ARNA years ago at 1.90 and rode it out to $99/share when they were bought out by Phizer Pharm. I would like to have my 5 grandkids share the spoils on this one. With a multi-pipe line, a couple should make it to the end of the line with FDA approval. At the number of shares I purchased multiple times I can afford to run for the hills if a sudden disaster should hit this one. This company is 21 miles from my home and I will stop by shortly and have a sit down with their home-based PR. person. Good luck to all. You may also want to look at BLRX {BIO-Line Inc }










👍️0
Walter4 Walter4 1 year ago
Data readout should be incoming shortly
👍️ 1
Monksdream Monksdream 2 years ago
PASG new 52 week low
👍️0
catinhat catinhat 3 years ago
So...anybody out there? Thoughts on upcoming abstract, etc?

Recent long.
👍️0
dealerschool2006 dealerschool2006 4 years ago
PASG down from panic selling due to the pricing of its underwritten public offering of 7,000,000 shares of its common stock at a public offering price of $22.00 per share.
👍️0

Your Recent History

NASDAQ
PASG
Passage Bio
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads